Vecna Robotics, a trailblazer in flexible material handling automation solutions, has announced the successful closure of its Series C funding round, securing an impressive $100 million. This financing, comprising $40 million in equity and debt, marks a significant milestone for the company, nearly doubling its valuation from previous rounds. Investors backing this round include Tiger…
In a milestone that fundamentally resets the parameters of the Central European venture landscape, Allonic has announced the successful closure of a $7.2 million pre-seed funding round. This injection of capital, reported as the largest pre-seed raise in Hungary’s history, signals an aggressive pivot toward “AI-native” hardware in the global robotics supply chain. The round…
A new force has entered the allergy‑therapeutics arena. Excellergy has announced a bold $70 million Series A round designed to advance its lead candidates—“trifunctional” Effector Cell Response Inhibitors (ECRIs)—toward clinical proof. The molecules aim to simultaneously strip IgE from bound immune cells, neutralize free IgE, and tamp down the receptor expression that fuels allergic cascades….
Norwegian startup Bsure has raised $2.1 million in seed funding to tackle one of the least glamorous yet most damaging issues inside modern IT systems: the silent sprawl of digital identities inside Microsoft environments. The round was led by Scale Capital, alongside returning U.S. investors doubling down on the company’s early traction. Identity clutter has…
Verituity, a leader in intelligent payout solutions, has successfully closed an $18.8 million funding round led by Sandbox Industries and Forgepoint Capital, with participation from Ardent Venture Partners and MTech Capital. This funding infusion is set to propel Verituity’s growth across banking, insurance, mortgage servicing, and energy sectors, marking a significant stride in its mission…
Shinobi Therapeutics, a trailblazer in immune evasive iPS cell therapies, has been awarded up to $59 million in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). This significant grant will accelerate the development of Shinobi’s pioneering iPS-T cell therapy, aimed at treating GPC3+ solid tumors. Dr. Yasumichi Hitoshi, Chief of…
Berlin-based deeptech startup Key Ward has emerged from stealth mode with a significant boost of €1 million in pre-seed funding. This round was spearheaded by Wellstreet, a prominent Swedish venture capital firm, and saw the participation of notable figures from industry giants including Siemens, Autodesk, Dassault Systèmes, Ansys, Altair, and Hexagon. The investment marks a…
In a landmark development for the quantum computing industry, Quantum Source has successfully closed a $50 million Series A funding round. The investment, spearheaded by Eclipse, was also supported by prominent investors including Standard Investments, Level VC, Canon Equity, as well as existing backers Pitango First, Grove Ventures, 10D, and Dell Technologies Capital. This latest…
In the often-overlooked world of vascular intervention, where small vessels dictate the success of life-sustaining treatments, VentureMed Group is betting that smarter engineering can deliver better outcomes. The Minneapolis-based medical device company has raised $28 million in Series C funding, led by S3 Ventures, with continued participation from Endeavour Vision and other existing backers. The…
Kanvas Biosciences, a pioneering spatial biology company, has announced a significant stride in its mission to revolutionize healthcare with microbiome-based therapies. With an additional $12.5 million in funding co-led by DCVC and Lions Capital LLC, and supported by FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures, alongside existing investors, the company’s total funding now…
